
Telehealth Prescribing Rules Extended Through 2026: What It Means for Ketamine Patients
The DEA and HHS extended pandemic-era telemedicine rules for controlled medications to December 31, 2026. Here is what the extension allows and what is still undecided.

What the FDA Wants You to Know About Compounded Ketamine
In October 2023 the FDA warned patients and providers about the risks of compounded ketamine, especially when taken at home without monitoring. Here is what the warning says and the questions to ask.

The Anaesthetic Much of the World Depends On
Long before ketamine was studied for depression, it was an essential anaesthetic. In hospitals with few resources there is often no affordable alternative, which is why the WHO has opposed restricting it.

Breaking Through in India: Ketamine Therapy Demonstrates Sustained Relief in Severe Depression
An Indian trial shows ketamine’s rapid and lasting antidepressant effects in drug-free patients with severe depression.
OnlineTalk to ProviderCall us
